Ls Investment Advisors, LLC Incyte Corp Transaction History

Ls Investment Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$79.87 - $87.53 $329,304 - $360,886	-4,123 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$76.02 - $100.5 $59,067 - $78,088	-777 Reduced 15.86%	4,123 $335,000
Q4 2020 Feb 10, 2021	SELL	$80.74 - $97.7 $779,383 - $943,098	-9,653 Reduced 66.33%	4,900 $426,000
Q3 2020 Nov 12, 2020	BUY	$85.07 - $109.69 $662,269 - $853,936	7,785 Added 115.03%	14,553 $1.31 Million
Q2 2020 Aug 10, 2020	SELL	$74.18 - $108.93 $38,870 - $57,079	-524 Reduced 7.19%	6,768 $704,000
Q1 2020 Apr 20, 2020	SELL	$63.18 - $85.97 $52,628 - $71,613	-833 Reduced 10.25%	7,292 $534,000
Q4 2019 Jan 31, 2020	BUY	$73.04 - $95.72 $118,397 - $155,162	1,621 Added 24.92%	8,125 $709,000
Q3 2019 Oct 31, 2019	BUY	$72.82 - $86.52 $12,525 - $14,881	172 Added 2.72%	6,504 $483,000
Q2 2019 Aug 07, 2019	SELL	$73.52 - $88.7 $1,543 - $1,862	-21 Reduced 0.33%	6,332 $538,000
Q1 2019 Apr 25, 2019	SELL	$63.56 - $88.17 $13,856 - $19,221	-218 Reduced 3.32%	6,353 $546,000
Q4 2018 Feb 01, 2019	SELL	$58.5 - $69.94 $28,957 - $34,620	-495 Reduced 7.01%	6,571 $418,000
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $2,778 - $3,340	-45 Reduced 0.63%	7,066 $488,000
Q2 2018 Jul 20, 2018	BUY	$60.85 - $83.98 $36,205 - $49,968	595 Added 9.13%	7,111 $476,000
Q1 2018 May 08, 2018	BUY	$83.06 - $100.98 $8,638 - $10,501	104 Added 1.62%	6,516 $543,000
Q4 2017 Feb 07, 2018	BUY	$93.56 - $116.6 $52,300 - $65,179	559 Added 9.55%	6,412 $607,000
Q3 2017 Oct 19, 2017	BUY	$109.15 - $138.27 $638,854 - $809,294	5,853	5,853 $683,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.